KITE & Gilead UK/I 2023 CAR-T Fellowship and Medical Grants Programme now open

Subject heading: KITE & Gilead UK/I 2023 CAR-T Fellowship and Medical Grants Programme now open

Do you have a project that could improve patient care in the field of CAR T-cell therapy and haemato-oncology?

The Kite and Gilead UK & Ireland Fellowship and Medical Grants Programme (GFP) is a medical grants funding stream that helps drive innovation and supports best practice sharing initiatives amongst healthcare professionals. Its aim is to help improve patient care within the field of CAR T-cell therapy and haemato-oncology. The GFP has funded nearly 350 projects since 2008.

The 2023 CAR-T GFP is accepting applications until June 30th.

The GFP accepts applications for projects that will add clinical value or address an unmet need in the care of patients within the field of CAR T-cell therapy and haemato-oncology. If you have a project that falls outside of this scope, but which will add clinical value or which investigates an area of unmet need within CAR T-cell therapy and haemato-oncology, you may still apply.

If you are interested in learning about the GFP or the application process, or to check if your project is eligible for a grant and apply, please visit the Gilead UK and Ireland website here. For general enquiries or questions about an application, please email [email protected] for support.

Disclaimer: The Kite and Gilead UK & Ireland Fellowship and Medical Grants Programme is fully operated and funded by Kite, a Gilead Company.

 

 

Date of preparation: April 2023

Code: UK-UNB-3782

Latest News

By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article
By BOPA Executive Committee on 30th October 2026

Acute and Supportive Oncology Clinical Consensus Statement

BOPA welcomes the Acute and Supportive Oncology Clinical Consensus Statement, to which we were pleased to contribute. It will be a benchmark for the sector, bringing direction and consistency as…

Read article
By BOPA, COSA, CAPhO & ISOPP on 13th October 2026

International Debate Webinar: Eastern and Western Medicine Can Co-exist – part of London Global Cancer Week 2026

Monday 2 November 2026 | 21:00 GMT (check your local time) Part of London Global Cancer Week 2026 Can Eastern and Western medicine co-exist in modern cancer care? Or do…

Read article
By Joseph Williams on 8th October 2026

BOPA 2026 Mentioned in Pharmaceutical Journal

Invest in aseptic services for future of specialised medicines, says chief pharmacist – The Pharmaceutical Journal Aseptic facilities are “absolutely essential” for hospitals to be involved in clinical trials and…

Read article